⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
businesswire.com
GH
Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033
businesswire.com
GH
Guardant Health Announces Proposed Public Offering of Common Stock
businesswire.com
GH
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
businesswire.com
GH
Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights
businesswire.com
GH
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
businesswire.com
GH
FDA Approves Guardant360 ® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
businesswire.com
GH
Guardant Health Announces Partnership with PathGroup Bringing Shield Blood Test to 250+ Hospitals and Health Systems in 25 States
businesswire.com
GH
The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients
prnewswire.com
DNLI
GH
PT
CRC
REGN
SNY
VRTX
IMCR
BMY
LAB
JNJ
AZN